Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Duchenne Muscular Dystrophy
Duchenne Muscular Dystrophy
Major US insurer snubs Sarepta's Duchenne drug
BioPharma Dive
Mon, 10/10/16 - 09:18 am
Anthem
insurerrs
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Exondys 51
Sarepta Wins Exclusive License, Collaboration Deal for European Rights To Summit's DMD Drug
Yahoo/Benzinga
Tue, 10/4/16 - 03:58 pm
Sarepta Therapeutics
Europe
Duchenne Muscular Dystrophy
Summit Therapeutics
ezutromid
The Woman Behind Sarepta Therapeutics' Success
Motley Fool
Mon, 09/26/16 - 09:38 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Kyndrisa
FDA
Janet Woodcock
Sarepta quickly lays out manufacturing, launch plans after delayed approval of Duchenne MD drug
Fierce Pharma
Sat, 09/24/16 - 01:32 pm
Sarepta Therapeutics
Kyndrisa
Duchenne Muscular Dystrophy
FDA approval in hand, Sarepta plans for future studies
BioPharma Dive
Fri, 09/23/16 - 09:44 am
FDA
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Kyndrisa
After Sarepta win, BioMarin appeals DMD patent ruling
BioPharma Dive
Fri, 09/23/16 - 09:35 am
Sarepta Therapeutics
Biomarin
patents
Duchenne Muscular Dystrophy
eteplirsen
Kyndrisa
FDA commissioner calls for Sarepta drug study to be retracted
Stat/Pharmalot
Thu, 09/22/16 - 12:18 pm
FDA
Sarepta Therapeutics
Robert Califf
Duchenne Muscular Dystrophy
eteplirsen
Sarepta's New Drug May Make It a Takeover
Investopedia
Wed, 09/21/16 - 10:50 pm
Sarepta Therapeutics
eteplirsen
Duchenne Muscular Dystrophy
M&A
Sarepta, Patients Win - But What Of Regulatory Oversight?
Seeking Alpha
Tue, 09/20/16 - 11:10 am
Sarepta Therapeutics
regulatory
Duchenne Muscular Dystrophy
FDA
eteplirsen
Sarepta to charge $300K for Duchenne drug. ‘We tried to be reasonable,’ CEO says
Stat/Pharmalot
Tue, 09/20/16 - 09:49 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
drug pricing
eteplirsen
Behind the Sarepta drug approval was intense FDA bickering
Stat/Pharmalot
Mon, 09/19/16 - 03:21 pm
Sarepta Therapeutics
FDA
Duchenne Muscular Dystrophy
eteplirsen
FDA approves Sarepta’s controversial drug for Duchenne muscular dystrophy
Stat
Mon, 09/19/16 - 10:07 am
FDA
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Sarepta Therapeutics: Wait, I Thought Turmoil at the FDA Was Good News?
Barron's
Thu, 09/15/16 - 07:16 pm
Sarepta Therapeutics
FDA
eteplirsen
Duchenne Muscular Dystrophy
Sarepta Drug Critic Departs FDA, Raising Hope for Approval
TheStreet.com
Wed, 09/14/16 - 09:43 am
Sarepta Therapeutics
FDA
eteplirsen
Duchenne Muscular Dystrophy
Sarepta: The Competition Is At The Gate
Seeking Alpha
Fri, 08/12/16 - 09:53 am
Sarepta Therapeutics
eteplirsen
Biomarin
Summit Therapeutics
PTC Therapeutics
Duchenne Muscular Dystrophy
Sarepta Stock Slides As FDA Sends Another Bad Signal On DMD
Investors.com
Fri, 07/15/16 - 10:15 am
Sarepta Therapeutics
FDA
Duchenne Muscular Dystrophy
Raxone
Kyndrisa
Santhera
Duchenne Drug Developer (Not Sarepta) Hit with Lengthy FDA Delay
TheStreet.com
Thu, 07/14/16 - 09:20 am
Raxone
Duchenne Muscular Dystrophy
Santhera
Why BioMarin's Shares Tumbled 11% in June
Motley Fool
Sun, 07/10/16 - 12:09 pm
Biomarin
M&A
Duchenne Muscular Dystrophy
Sanofi
drisapersen
Kyndrisa
Duchenne drug rejected in US is available in England
Pharma Times
Fri, 07/8/16 - 10:16 am
Duchenne Muscular Dystrophy
England
PTC Therapeutics
Translarna
Sarepta's Pathway To Approval
Seeking Alpha
Fri, 06/24/16 - 09:30 am
Sarepta Therapeutics
eteplirsen
Duchenne Muscular Dystrophy
FDA
Pages
« first
‹ previous
…
7
8
9
10
11
12
13
14
15
…
next ›
last »